Market Tracker

04/17 6:05pm ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

64.13
Data as of Apr 17
 +1.23 / +1.96%
Today’s Change
23.87
Today|||52-Week Range
80.42
+21.92%
Year-to-Date
No recent news for Ligand Pharmaceuticals Inc.

Today’s Trading

Previous close62.90
Today’s open62.51
Day’s range61.28 - 66.21
Volume364,140
Average volume (3 months)382,519
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+54.13%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+56.02%
P/E ratio149.1
Price/Sales21.82
Price/Book26.38

Competitors

 Today’s
change
Today’s
% change
PDLIPDL BioPharma Inc+0.16+1.94%
AUXLAuxilium Pharmaceuti...-0.49-1.85%
ARNAArena Pharmaceutical...-0.12-1.90%
INSYInsys Therapeutics I...+1.88+5.11%
Data as of 3:59pm ET, 04/17/2014

Financials

Next reporting dateMay 7, 2014
EPS forecast (this quarter)$0.25
Annual revenue (last year)$49.0M
Annual profit (last year)$8.8M
Net profit margin18.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John L. Higgins
Chief Operating Officer &
Executive Vice President
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts